MSU
RMD icon

Maple Securities USA’s ResMed RMD Stock Holding History

Maple Securities USA’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-15,649
Closed -$737K – 328
2013
Q4 		$737K Buy
+15,649
New +$792K 0.05% 153
2013
Q3 		– Sell
-31,928
Closed -$1.44M – 501
2013
Q2 		$1.44M Buy
+31,928
New +$1.51M 0.13% 142

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Maple Securities USA's RMD Position: Q1 2014 in Review

Maple Securities USA sold out of ResMed (RMD) in Q1 2014, closing a stake of 15,649 shares — an estimated $737K sold.

Maple Securities USA first reported a position in RMD in Q2 2013 and held it in 2 quarters. The position peaked at $1.44M in Q2 2013. 318 funds tracked by Wall St. Rank hold RMD as of Q1 2014.

  • Maple Securities USA reported no remaining ResMed position as of Q1 2014 after selling out during the quarter.
  • Maple Securities USA sold 15,649 ResMed shares in Q1 2014, an estimated $737K.
  • Maple Securities USA first reported a position in ResMed in Q2 2013 and held it in 2 quarters.
  • Maple Securities USA's ResMed position peaked at $1.44M in Q2 2013.
  • 318 funds tracked by Wall St. Rank held ResMed as of Q1 2014.

Based on Maple Securities USA's 13F filing for Q1 2014, filed 24 Apr 2014.